The FDA has approved risperidone once-monthly, extended-release injectable suspension for maintenance treatment of bipolar I disorder in adults.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/fda-expands-uzedy-indication-bipolar-i-disorder-2025a1000rk1?src=rss
Author :
Publish date : 2025-10-13 16:48:00
Copyright for syndicated content belongs to the linked Source.
